Patent Assignment
Reel/Frame 049401/0181
Assignment of Assignor's Interest
Recorded: 2019-06-07
Pages: 3
Assignor
SHORTIS, NICOLAS PETER
Executed: 2015-06-02
Assignee
SALIX PHARMACEUTICALS, INC.
400 SOMERSET CORPORATE BLVD., BRIDGEWATER, NEW JERSEY, 08807
Covered Property
(1)
Use of Aminosalicylates in Diarrhoea-Predominent Irritable Bowel Syndrome
Application:
16/407,458 →
Publication:
US 2020/0101090
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
May 6, 2020
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH IRELAND LIMITED; SALIX PHARMACEUTICALS, LTD; SALIX PHARMACEUTICALS, INC.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 052589/0813 →
Security Interest
May 6, 2020
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH IRELAND LIMITED; SALIX PHARMACEUTICALS, LTD; SALIX PHARMACEUTICALS, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 052589/0884 →
Release of Security Interest
Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.
Reel/Frame 070778/0199 →